Efficacy of azilsartan on left ventricular diastolic dysfunction compared with candesartan: J-TASTE randomized controlled trial

Characterized by ventricular and vascular stiffness, heart failure with preserved ejection fraction (HFpEF) has led to high morbidity and mortality. As azilsartan is an angiotensin receptor blocker with the highest myocardial and vascular affinities, azilsartan may improve the left ventricular (LV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Shin, Takahama, Hiroyuki, Asakura, Masanori, Abe, Yukio, Ajioka, Masayoshi, Anzai, Toshihisa, Arikawa, Takuo, Hayashi, Takaharu, Higashino, Yorihiko, Hiramitsu, Shinya, Iwahashi, Noriaki, Izumi, Chisato, Kimura, Kazuo, Kinugawa, Koichiro, Kioka, Hidetaka, Lim, Young-Jae, Matsuoka, Ken, Matsuoka, Satoshi, Motoki, Hirohiko, Nakamura, Sunao, Nakayama, Takafumi, Nomura, Akihiro, Sasaoka, Taishi, Takiuchi, Shin, Toyoda, Shigeru, Ueda, Tomoya, Watanabe, Tetsuya, Yamada, Akira, Yamamoto, Masayoshi, Sozu, Takashi, Kitakaze, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397297/
https://www.ncbi.nlm.nih.gov/pubmed/37532820
http://dx.doi.org/10.1038/s41598-023-39779-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397297/
https://www.ncbi.nlm.nih.gov/pubmed/37532820
http://dx.doi.org/10.1038/s41598-023-39779-y

Ejemplares similares